Medicinova, Inc. MNOV
Key Stats
- Today's Range
- $1.29 – $1.35
- 50-Day Range
- $1.22 – $1.55
- 52-Week Range
- $1.17 – $1.96
- Volume
- 64K shs
- Average Volume
- 59K shs
- Market Cap
- $65.96 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 1.67
- Price / Sales
- 110.55
Short Interest
- Short Interest
- 4.32%
- Days to Cover
- 40.92
Financials (TTM)
- Revenue
- $596,641
- Net Income
- $-11,720,095
- Net Margin
- -1964.35%
- Return on Equity
- -29.74%
- Debt-to-Equity
- —
About Medicinova, Inc.
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.